Workflow
*ST天山(300313) - 2019 Q1 - 季度财报
TIANSHAN BIOTIANSHAN BIO(SZ:300313)2019-04-25 16:00

Financial Performance - Total revenue for Q1 2019 was CNY 28,785,050.87, representing a 6.52% increase compared to CNY 27,023,861.24 in the same period last year[7]. - Net profit attributable to shareholders was CNY -8,436,733.54, a decrease of 59.04% from CNY -5,304,879.54 year-over-year[7]. - Total operating revenue for Q1 2019 was CNY 28,785,050.87, an increase of 6.53% from CNY 27,023,861.24 in the previous period[101]. - Net loss for Q1 2019 was CNY -8,094,380.78, compared to a net loss of CNY -5,646,845.52 in the same period last year, representing a deterioration of 43.25%[103]. - The total comprehensive loss for Q1 2019 was CNY -8,941,453.82, slightly improved from CNY -9,792,779.38 in the previous period[103]. - The company's gross profit margin decreased, with operating profit recorded at CNY -7,477,309.89, compared to CNY -5,320,402.88 in the previous period[101]. Cash Flow and Liquidity - Net cash flow from operating activities was CNY -42,361,429.38, a decline of 386.16% compared to CNY -8,713,418.28 in the previous year[7]. - Cash inflow from operating activities increased by 160.42% to ¥73,102,659.74, attributed to income from poverty alleviation initiatives[26]. - Cash outflow from operating activities rose by 213.89% to ¥115,464,089.12, mainly due to increased expenses related to cattle procurement[26]. - Cash and cash equivalents decreased by 37.16% to ¥151,993,956.75 due to payments for foreign trade and bank loan repayments[22]. - The ending balance of cash and cash equivalents decreased to 151,991,495.96 CNY from 241,873,584.47 CNY at the beginning of the period[111]. Assets and Liabilities - Total assets increased by 97.71% to CNY 1,366,063,205.67 from CNY 690,949,583.86 at the end of the previous year[7]. - Total liabilities decreased from CNY 1,197,229,068.79 to CNY 1,169,202,817.19, a decline of about 2.3%[95]. - The company's total equity decreased from CNY 205,801,842.30 to CNY 196,860,388.48, a reduction of approximately 4.3%[96]. - Current liabilities decreased from CNY 1,077,384,965.41 to CNY 1,049,348,389.22, a reduction of about 2.6%[95]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 14,810[11]. - The largest shareholder, Tianshan Animal Husbandry Development Co., Ltd., held 18.35% of the shares, amounting to 57,426,801 shares[11]. - Tianshan Agriculture holds 57,426,801 shares, accounting for 18.35% of the total share capital, with 100% of these shares pledged[39]. - The company has not implemented any share buyback plans as of the report date[40]. Operational Risks and Challenges - The company faces significant risks from disease outbreaks in livestock, which could severely impact production and operations[30]. - The company is under investigation by the China Securities Regulatory Commission for suspected violations of information disclosure laws, which may impact its operations[34]. - The company has initiated measures to safeguard its rights, including collateralizing accounts receivable from Daxiang Advertising[34]. Future Outlook and Strategic Initiatives - The company provided a positive outlook for the upcoming quarters, projecting a revenue growth of 10-15% for the next fiscal year[48]. - New product launches are expected to contribute to growth, with two major products set to be released in Q2 2019[48]. - The company is expanding its market presence, targeting new regions in Southeast Asia, aiming for a 25% increase in market share by the end of 2019[48]. - The company plans to enhance its product quality and expand sales channels to mitigate performance risks[30]. Research and Development - Ongoing research and development efforts are focused on enhancing product features, with an investment of 50 million yuan allocated for R&D in 2019[48]. - The company reported an increase in research and development expenses to CNY 438,112.00, up from CNY 387,953.75 in the previous period, reflecting ongoing investment in innovation[101]. Compliance and Governance - The company has established an independent financial department with dedicated personnel and a separate accounting system to ensure financial independence[54]. - The governance structure of the listed company is independent and complete, ensuring that the board and supervisory committee exercise their powers independently[54]. - The company has committed to maintaining compliance with regulatory standards, ensuring no legal barriers affect its operations[73].